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endovascular repair of abdominal aortic aneurysms based
on size threshold
Charles J. Keith Marc A. Passman, Michael J. Gaffud, Zdenek
Novak, Benjamin J. Pearce, Thomas C. Matthews, Mark A.
Patterson, and William D. Jordan
Introduction: Size threshold for operative repair of
abdominal aortic aneurysms (AAAs) has been determined
based on risks and outcomes of open repair vs surveillance.
The inﬂuence of endovascular aneurysm repair (EVAR) on this
threshold is less established. The purpose of this study is to
determine whether long-term outcomes following EVAR are
affected by maximum diameter at the time of treatment.
Methods: Patients undergoing EVAR with modular stent
grafts from 2000 to 2011 were identiﬁed from a prospec-
tively maintained database and stratiﬁed by maximum
aortic diameter at the time of repair: small (4.0-4.9 cm),
medium (5.0-5.9 cm), and large (=6.0 cm). Comparisons of
demographics, indications for repair, perioperative compli-
cations, and long-term outcomes were made using analysis
of variance, ?2, and Kaplan-Meier plots.
Results: Seven hundred forty patients were identiﬁed:
157 (21.2%) small, 374 (50.5%) medium, and 209 (28.2%)
large. Patients differed by mean age (69.3 ± 8.09, 71.7 ±
8.55, and 73.6 ± 8.77 years for small, medium, and large,
respectively; P < .001), coronary artery disease (42% small,
57% medium, 51.2% large; P = .01), prior coronary angio-
plasty (14.6% small, 18.2% medium, 9.6% large; P = .02),
congestive heart failure (5.7% small, 15.2% medium, 19.6%
large; P = .01), prior vascular surgery (7% small, 15.8%
medium, 10% large; P = .016), and chronic obstructive
pulmonary disease (21% small, 27% medium, 33% large; P =
.038). Small AAAs were more frequently symptomatic
(19.7% small, 7.5% medium, 8.1% large; P < .001). There
was no difference in perioperative complication rates
(P = .399), expansion =5 mm (2.6% small, 5.6% medium,
7.2% large; P = .148), or all-type endoleak (40.8% small,
41.7% medium, 44.5% large; P = .73). Small AAAs developed
fewer type I endoleaks (5.1% vs 6.95% medium and 14.8%
large; P = .001). Compared with small AAAs, both medium
(P = .39) and large (P < .001) required secondary inter-
vention more frequently, with hazard ratios of 2.32 (95%
conﬁdence interval, 1.045-5.156) and 4.74 (95% conﬁdence
interval, 2.115-10.637), respectively. Ten-year survival was
72%, 63.1%, and 49.8% in the small, medium, and large*Full articles available online at www.jvascsurg.org
1078-5884/$ e see front matter
http://dx.doi.org/10.1016/S1078-5884(13)00676-Xgroups, respectively (P < .001) with one rupture-related
death after EVAR in the large group. All-cause mortality
differed among the 75- to 84-year-old patients (30.4%
small, 51.6% medium, 55.7% large; P = .017).
Conclusions: EVAR for small AAAs shows improved long-
term outcomes than for age-matched patients with larger
aneurysms.A case-control study of intentional occlusion of accessory
renal arteries during endovascular aortic aneurysm repair
Rafael D. Malgor, Gustavo S. Oderich, Terri J. Vrtiska, Manju
Kalra, Audra A. Duncan, Peter Gloviczki, Stephen Cha, and
Thomas C. Bower
Objective: The purpose of this study was to evaluate out-
comes of patients treated by intentional coverage of acces-
sory renal artery (ARA) during endovascular abdominal
aneurysm repair (EVAR).
Methods: The clinical data of 119 patients (110 male and
nine female; mean age, 75 years) from a cohort of 811 pa-
tients treated by EVAR from 1998 to 2009 was reviewed.
Patients who had intentional coverage of at least one ARA
(group A) were compared with two control groups, which
included patients with no ARA (group B) and those who had
ARA preserved during EVAR (group C). All three groups of
patients were matched for age, gender, hypertension, and
preoperative estimated glomerular ﬁltration rate (eGFR).
Paired pre- and postoperative computed tomography
angiography was analyzed for the presence and volume of
kidney infarction. End points were changes in eGFR, chronic
kidney disease (CKD) stage, blood pressure measurements,
presence and volume of kidney infarction, freedom from
reintervention, and endoleak.
Results: There were 42 patients in group A, 42 in group B,
and 35 in group C. Demographics, cardiovascular risk fac-
tors, and CKD classiﬁcation were similar in all three groups.
Among patients in group A, 44 ARAs were intentionally
covered with ARAs originating from the proximal neck in 22
patients, the aneurysm sac in 20, and the iliac arteries in
two. There was one (1%) early death in the entire study.
Early morbidity was similar in all three groups, including
four patients (9%) in group A, four (9%) in group B, and four
(11%) in group C (P = .9). Six (5%) patients had >25%
decrease in eGFR, including two who had ARA coverage.
None of the patients required dialysis. After a mean follow-
up of 37 months, there were no differences in late renal
function deterioration, changes in eGFR, CKD stage, or
blood pressure measurements among the three groups.
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from the aneurysm sac developed a type II endoleak
requiring coil embolization. Kidney infarction was noted in
28 patients (67%) in group A. Freedom from reintervention
at 2 years was similar in groups A (64%), B (80%), and C
(96%; P = .09).
Conclusions: Intentional ARA occlusion during EVAR was
not associated with changes in renal function or blood
pressure measurements, even when performed in patients
with more advanced renal dysfunction. Type II endoleak
may result from persistent outﬂow into large (>3 mm) ARAs
that arise from the aneurysm sac.Endovascular treatment for isolated acute abdominal
aortic dissection
George N. Kouvelos, George Vourliotakis, Eleni Arnaouto-
glou, Nektario Papa, Stavros Avgos, Michalis Peroulis,
George Papadopoulos, and Miltiadis I. Matsagkas
Background: Isolated acute abdominal aortic dissection
(IAAAD) is considered an unusual clinical entity and is tra-
ditionally treated by open surgical repair. We report our
single-center experience during the last 9 years, evaluating
the outcomes after endovascular repair in this patient
population.
Methods: All patients with a diagnosis of IAAAD treated
in our institute were included in this retrospective review.
Between January 2004 and December 2012, 38 patients
suffering from an acute aortic dissection were referred
regionally for intervention to our department: 24 (63.2%)
with a thoracic aortic dissection type B and 14 patients
(36.8%, all male; median age, 65 years) with an IAAAD.
Demographics, perioperative, procedure-speciﬁc, and fol-
low-up data were prospectively aggregated in an electronic
database.
Results: Patients suffering from IAAAD presented with
acute abdominal pain (n = 13) and acute lumbar pain (n =
1). Insufferable pain and enlargement of the aorta were the
main indications for treatment. Mean (± standard deviation)
maximal abdominal aortic diameter at presentation was
3.5 ± 0.94 cm (range, 2.6-5.1 cm). None of these patients
had a concomitant thoracic aortic dissection. All patients
were treated by endovascular means, with a primary
technical success rate of 100%. Two patients (14%) died
perioperatively from cardiac causes. Median hospital stay
was 4.5 days (range, 3-16 days). During a mean follow-up
period of 37.41 ± 23.56 months (range, 8-82 months; me-
dian, 32.5 months), two patients experienced primary
treatment failure needing reintervention that led to a suc-
cessful outcome. The cumulative free-from-reintervention
rate was estimated 90.9% at 58 months (standard error,
8.7%). A full aortic remodeling without any events was
noted in all other patients during the follow-up period.
Conclusions: Based on our series, IAAAD may represent
a not so rare clinical entity as generally thought, suggesting
that it may be underdiagnosed. Endovascular treatment of
IAAAD appears to be a feasible and efﬁcient therapeuticapproach and might be considered as the ﬁrst-line treat-
ment in all patients with suitable anatomy.Clinical consequence of bare metal stent and stent graft
failure in femoropopliteal occlusive disease
Shant M. Vartanian, Paul C. Johnston, Joy P. Walker, Sara J.
Runge, Charles M. Eichler, Linda M. Reilly, Jade S. Hiramoto,
and Michael S. Conte
Objective: The optimal role for bare metal stents (BMS) or
stent grafts (SG) in femoropopliteal occlusive disease
(FPOD) is as of yet undeﬁned. Understanding the clinical
consequences of failure can help guide initial treatment
decisions. The goal of this study was to deﬁne the nature,
frequency, and risk factors for adverse clinical events rela-
ted to BMS and SG failure in FPOD.
Methods: This is a single-institution retrospective re-
view of primary endovascular interventions for FPOD
using either a BMS or SG, from September 2007 through
October 2011. Patients were excluded if they had any
previous lower extremity interventions. Patient de-
mographics, indications for intervention, anatomic
characteristics, procedural details, clinical outcomes,
and reintervention details were reviewed. Clinical out-
comes included the composite end point of any rein-
tervention, amputation, or stenosis, acute limb ischemia
(ALI), and the composite end point of major adverse
limb events, which included a need for bypass, throm-
bolysis, or major amputation.
Results: Seventy-one limbs were treated with BMS and 63
with SG. Although patient demographics were largely sim-
ilar between cohorts, key differences included indication for
intervention (percent claudication BMS vs SG, 34/71 (48%)
vs 42/63 (67%); P < .05) and the TransAtlantic Inter-Society
Consensus II classiﬁcation of lesions in the claudicant sub-
group (TransAtlantic Inter-Society Consensus D BMS vs SG,
4/34 (12%) vs 17/42 (40%); P < .01). Freedom from rein-
tervention at 1 year was better in the SG group (75% vs
64%; hazard ratio, 0.46; 95% conﬁdence interval, 0.25-0.78;
P < .01). Freedom from major adverse limb events was not
different between groups; however, SG thrombosis resulted
in a more frequent need for thrombolysis. On multivariate
analysis, treating with a BMS vs SG was a signiﬁcant pre-
dictor for freedom from thrombolysis (hazard ratio, 0.53;
conﬁdence interval, 0.37-0.76; P< .01). ALI during follow-up
was seen only in the SG group (nine vs zero events, log-
rank; P < .02).
Conclusions: Failure modes of BMS and SG used to treat
FPOD differ, and the clinical consequences may not be
benign. Claudicants may not revert back to claudication
with treatment failure. Although the overall reintervention
rate at 1 year is lower for SG compared to BMS, we
observed a higher rate of ALI and need for thrombolysis
with SG failure. In light of these differential risks of treat-
ment failure, we believe that the use of SG as initial
therapy for FPOD should be carefully deliberated and
mandates close postoperative surveillance.
738 AbstractsPercutaneous transluminal angioplasty results in improved
physical function but not balance in patients with
intermittent claudication
Risha Arun Gohil, Katherine A. Mockford, Fayyaz A. Mazari,
Junaid A. Khan, Natalie Van Vanicek, Ian C. Chetter, and
Patrick A. Coughlin
Objective: The aim of this study was to identify whether
revascularization by percutaneous transluminal angio-
plasty (PTA) for patients with intermittent claudication
improved measures of functional performance including
balance.
Methods: A prospective observational study was per-
formed at a single tertiary vascular center. Patients with
symptomatic intermittent claudication (Rutherford grades
1-3) were recruited to the study. Participants were assessed
at baseline (pre-PTA) and then 3, 6, and 12 months post-
PTA for markers of (1) lower limb ischemia (treadmill
walking distances and ankle-brachial pressure index), (2)
physical function (6-minute walk, Timed Up and Go, and
chair stand time), (3) balance impairment using compu-
terized dynamic posturography with the Sensory Organiza-
tion Test, and (4) quality of life (VascuQoL and Short Form
Health Survey [SF-36]).
Results: Forty-three participants underwent PTA. Over 12
months, a signiﬁcant improvement was demonstrated in
initial (P = .04) and maximum treadmill walking distance
(P = .019). Physical functional ability improved across all
outcome measures (P < .02), and some domains of both
generic (P < .03) and disease-speciﬁc quality of life (P <
.01). No signiﬁcant improvement in balance was demon-
strated by the Sensory Organization Test (P = .24).
Conclusions: Balance impairment is common in claudi-
cants and does not improve with revascularization. Further
research regarding effective treatment of balance impair-
ment is required in this speciﬁc group of patients.Initial and 3-year results after subintimal versus
intraluminal approach for long femoralpopliteal occlusion
treated with a self-expandable nitinol stent
Yoshimitsu Soga, Osamu Iida, Kenji Suzuki, Keisuke Hirano,
Daizo Kawasaki, Yoshiaki Shintani, Nobuhiro Suematsu, and
Terutoshi Yamaoka
Background: Intraluminal femoropopliteal stenting en-
ables favorable dilation and good immediate results; how-
ever, whether this contributes to long-term patency is
unclear. We compared patency after femoropopliteal
stenting for a long occlusion using either an intraluminal or
subintimal approach.
Methods: Between January 2004 and December 2011,
902 endovascular procedures using either an intraluminal
approach (651 procedures) or a subintimal approach (251
procedures) for long femoropopliteal occlusion were ana-
lyzed retrospectively. The outcomes of this study were
periprocedural complication; primary, assisted-primary, and
secondary patency; and overall survival.Results: The mean follow-up period of survivors was 29 ±
16 months. Between the intraluminal and subintimal
approach, technical success (91% vs 90%; P = .71) and
periprocedural complications (11% vs 13%; P = .34) were
similar. However, procedure time was signiﬁcantly longer
for the intraluminal approach (126 ± 63 minutes vs 98 ± 49
minutes; P = .003). The improvement of ankle-brachial index
was also similar. A quarter of cases started with the intra-
luminal approach were switched to a subintimal approach.
There was no signiﬁcant difference in primary, assisted-
primary and secondary patency at 3 years between the two
groups (55% vs 53%; P = .30; 65% vs 74%; P = .11; and 80%
vs 85%; P = .37). The 3-year overall survival also did not
differ signiﬁcantly between groups (84% vs 86%; P = .55).
After adjusting for baseline differences, the subintimal
approach was found to be similar to the intraluminal
approach for primary patency (hazard ratio, 1.21; 95%
conﬁdence interval, 0.94-1.56; adjusted P = .14).
Conclusions: Initial result and 3-year patency was similar
in both approaches. Given the longer procedure time and
high crossover rate, we suggest that a subintimal approach
may be preferred in the treatment of long femoralpopliteal
occlusions with stenting.Patient radiation exposure during percutaneous
endovascular revascularization of the lower extremity
Einat Segal, Ido Weinberg, Isaac Leichter, Alexander Klimov,
Jay Giri, Allan I. Bloom
Background: Percutaneous endovascular revasculariza-
tion is emerging as the ﬁrst line treatment for peripheral
artery disease for both intermittent claudication and
chronic critical limb ischemia. Radiation doses for these
interventions have not been well documented.
Methods: A single center retrospective study of thera-
peutic endovascular lower extremity interventions per-
formed between September 2006 and December 2011 was
undertaken. Collected data included patient demographics,
procedure indication, procedural access, anatomic location
of occlusive disease (pelvis, thigh, below-knee, or multi-
level), and radiation exposure parameters including dose
area product (DAP) and ﬂuoroscopy time.
Results: Data was available for 382 procedures performed in
313 patients. Eighteen procedures bilateral procedures were
excluded. Access site and complete anatomic data were avail-
able for 346 procedures. DAP was signiﬁcantly higher for pro-
cedures performed in the pelvis compared with thigh
procedures (179.6 vs 63.2 Gy*cm2; P< .0001) and below-knee
procedures (179.6 vs 28.9 Gy*cm2; P< .0001), despite shorter
ﬂuoroscopy times (11.8 vs 16.4 minutes; P< .0001 and 11.1 vs
31.06 minutes; P < .0001, respectively). Procedure access-site
affected radiation dose as well; contralateral up-and-over ac-
cess resulted in a higher DAP than antegrade access (112.2 vs
42.6 Gy*cm2; P< .0001). In a multivariable analysis, anatomic
location of the procedure showed the strongest association
with radiation dose (P < .0001).
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for lower extremity peripheral artery disease involves a sub-
stantial radiation dose, comparable, on average, to a com-
puted tomography scan of the abdomen and pelvis.
Procedures performed in the pelvis for intermittent claudi-
cation involve more radiation than thigh or below-knee
procedures for chronic critical limb ischemia. Radiation dose
should be considered when planning these procedures.Safety of carotid endarterectomy following thrombolysis
for acute ischemic stroke
Yao Pey Yong, John Saunders, Said Abisi, Nikola Sprigg,
Krishna Varadhan, Shane MacSweeney, and Nishath Altaf
Background: The timing of carotid endarterectomy (CEA)
following thrombolysis for acute ischemic stroke remains
controversial. We have described our unit's experience and
performed a systematic review and pooled data synthesis of
the safety of CEA in this group of patients.
Methods: Retrospective analysis of patients who had
undergone CEA following thrombolysis between 2010 and2012 was performed. A systematic review of the literature
was also performed using PUBMED, EMBASE, and major
conference proceedings. The primary outcome measure was
30-day postoperative intracerebral hemorrhage (ICH) and
ischemic stroke. The secondary outcome measures were 30-
day postoperative all-cause morbidity and mortality.
Results: Seven patients underwent CEA following throm-
bolysis with mean age ± standard deviation of 70.57 ± 7.57.
Five were men and ﬁve had CEA under local anesthesia. CEA
was performed in median of 7 days (range, 2-12) after onset
of stroke. Thirty-day morbidity was 14% (1/7) with one
patient who experienced ICH postoperatively. There was no
mortality. Nine studies were identiﬁed for systemic review.
Seventy patients were included in the pooled data syn-
thesis. One patient (1%) experienced postoperative ICH.
When our series was included, the 30-day postoperative ICH
was 3% (2/77). The overall 30-day postoperative morbidity
was 4% (3/77), and there was no mortality.
Conclusions: Despite slightly higher rates of postoperative
hemorrhagic strokes than those in randomized trials, CEA
appears safe following thrombolysis for acute ischemic stroke.
However, more data on the timing of surgery is needed.
